[go: up one dir, main page]

NO20022816L - Behandling av virale infeksjoner ved anvendelse av Levovirin - Google Patents

Behandling av virale infeksjoner ved anvendelse av Levovirin

Info

Publication number
NO20022816L
NO20022816L NO20022816A NO20022816A NO20022816L NO 20022816 L NO20022816 L NO 20022816L NO 20022816 A NO20022816 A NO 20022816A NO 20022816 A NO20022816 A NO 20022816A NO 20022816 L NO20022816 L NO 20022816L
Authority
NO
Norway
Prior art keywords
levovirin
treatment
viral infections
infections
viral
Prior art date
Application number
NO20022816A
Other languages
English (en)
Other versions
NO20022816D0 (no
Inventor
Robert Tam
Original Assignee
Icn Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icn Pharmaceuticals filed Critical Icn Pharmaceuticals
Publication of NO20022816D0 publication Critical patent/NO20022816D0/no
Publication of NO20022816L publication Critical patent/NO20022816L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
NO20022816A 1999-12-23 2002-06-13 Behandling av virale infeksjoner ved anvendelse av Levovirin NO20022816L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/471,513 US6518253B1 (en) 1999-11-19 1999-12-23 Treatment of viral infections using the L-isomer of ribavirin
PCT/US2000/034610 WO2001046212A1 (en) 1999-12-23 2000-12-15 Treatment of viral infections using levovirin?tm¿

Publications (2)

Publication Number Publication Date
NO20022816D0 NO20022816D0 (no) 2002-06-13
NO20022816L true NO20022816L (no) 2002-06-13

Family

ID=23871906

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022816A NO20022816L (no) 1999-12-23 2002-06-13 Behandling av virale infeksjoner ved anvendelse av Levovirin

Country Status (22)

Country Link
US (2) US6518253B1 (no)
EP (1) EP1246832A1 (no)
JP (1) JP2003518134A (no)
KR (1) KR20030016213A (no)
CN (1) CN1409721A (no)
AU (1) AU2281601A (no)
BR (1) BR0016163A (no)
CA (1) CA2384110A1 (no)
CZ (1) CZ2002968A3 (no)
HK (1) HK1050011A1 (no)
HR (1) HRP20020486A2 (no)
HU (1) HUP0400500A2 (no)
IL (1) IL148510A0 (no)
MX (1) MXPA02006259A (no)
NO (1) NO20022816L (no)
PL (1) PL356640A1 (no)
RU (1) RU2002112248A (no)
SI (1) SI21042A (no)
SK (1) SK6252002A3 (no)
WO (1) WO2001046212A1 (no)
YU (1) YU47702A (no)
ZA (1) ZA200202739B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
CA2426187C (en) 2000-10-18 2011-08-16 Pharmasset Limited Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation
ES2260683T3 (es) * 2002-08-12 2006-11-01 F. Hoffmann-La Roche Ag Procedimiento para producir una ribofuranosa.
WO2004052905A2 (en) * 2002-12-10 2004-06-24 F. Hoffmann-La Roche Ag Antiviral nucleoside derivatives
US7125853B2 (en) * 2003-01-07 2006-10-24 Kemin Pharma B.V.B.A. Bicyclic carbohydrate compounds useful in the treatment of infections caused by Flaviviridae sp., such as hepatitis C and bovine viral diarrhea viruses
US20050009848A1 (en) * 2003-07-10 2005-01-13 Icn Pharmaceuticals Switzerland Ltd. Use of antivirals against inflammatory bowel diseases
US6930093B2 (en) * 2003-07-10 2005-08-16 Valeant Research & Development Use of ribofuranose derivatives against inflammatory bowel diseases
US20050182252A1 (en) 2004-02-13 2005-08-18 Reddy K. R. Novel 2'-C-methyl nucleoside derivatives
US20140010783A1 (en) * 2012-07-06 2014-01-09 Hoffmann-La Roche Inc. Antiviral compounds
EP3105238A4 (en) 2014-02-13 2017-11-08 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
CN106687118A (zh) 2014-07-02 2017-05-17 配体药物公司 前药化合物及其用途
JP2021509907A (ja) 2018-01-09 2021-04-08 リガンド・ファーマシューティカルズ・インコーポレイテッド アセタール化合物およびその治療的使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5767097A (en) * 1996-01-23 1998-06-16 Icn Pharmaceuticals, Inc. Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes
US6150337A (en) * 1996-01-23 2000-11-21 Icn Pharmaceuticals, Inc. Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytes
BR9712527A (pt) * 1996-10-16 2000-03-08 Icn Pharmaceuticals L-nucleosìdeos monocìclicos, análogos e seus empregos

Also Published As

Publication number Publication date
HK1050011A1 (zh) 2003-06-06
US6518253B1 (en) 2003-02-11
WO2001046212A1 (en) 2001-06-28
HRP20020486A2 (en) 2004-08-31
MXPA02006259A (es) 2003-01-28
CZ2002968A3 (cs) 2003-10-15
HUP0400500A2 (hu) 2004-07-28
NO20022816D0 (no) 2002-06-13
SK6252002A3 (en) 2003-02-04
EP1246832A1 (en) 2002-10-09
KR20030016213A (ko) 2003-02-26
BR0016163A (pt) 2002-08-13
YU47702A (sh) 2005-11-28
CN1409721A (zh) 2003-04-09
IL148510A0 (en) 2002-09-12
US20030092644A1 (en) 2003-05-15
JP2003518134A (ja) 2003-06-03
CA2384110A1 (en) 2001-06-28
SI21042A (sl) 2003-04-30
PL356640A1 (en) 2004-06-28
ZA200202739B (en) 2003-09-23
RU2002112248A (ru) 2004-01-20
AU2281601A (en) 2001-07-03

Similar Documents

Publication Publication Date Title
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
DK0821690T3 (da) Nukleotidanaloger til behandling af virusinfektioner
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
PL376454A1 (en) 1-acyl-pyrrolidine derivatives for the treatment of viral infections
AU2158000A (en) Treatment of hepatitis c virus infections with interleukin-10
NO20022245D0 (no) Onkolyttiske kombinasjoner for behandling av cancer
GB0329254D0 (en) Treatment of viral infections
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
NO20022816L (no) Behandling av virale infeksjoner ved anvendelse av Levovirin
DE60021065D1 (de) Virus behandlung
NO940810D0 (no) Behandling av virusinfeksjoner
PT1220858E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes virais
GB0329958D0 (en) Treatment of viral infections
AP2002002432A0 (en) Treatment of viral infections
NO20032769D0 (no) Kombinasjonsmetode for behandling av virale infeksjoner
AU4145999A (en) Topical drug for the treatment of viral infections
ATE267598T1 (de) Virus behandlung
NO20014477L (no) Behandling av osteoartritis
PT1152768E (pt) Tratamento de infeccoes virais cronicas com m. vaccae
NO991244D0 (no) Anvendelse av antiflogistika ved inhibering av virale infeksjoner
GB0023198D0 (en) Treatment of DNA viral infections
SI1220858T1 (en) Oxazinoquinolones useful for the treatment of viral infections
GB0023200D0 (en) Synergistic treatment of DNA viral infections
DK1122245T3 (da) 2-Aminobenzoxazinoner til behandling af virale infektioner
ID29414A (id) Pengobatan depresi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application